abstract |
DIPEPTIDIL PEPTIDASE-IV INHIBITORS. The present invention generally relates to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic processes for preparing such compounds, processes for inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treating DPP-IV mediated diseases, in particular Type 2 diabetes. |